Purchase Order 75N91018P00277
Award Date 4/2/18
Potential Completion Date 5/3/18
Potential Value $6.2K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Piscataway, NJ 08854, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>The National Cancer Institute awarded a purchase order to Genscript USA Inc. for $3,666.96 on June 28, 2017. Performance occurs in Piscataway, New Jersey. The order procures peptide services on a firm fixed price basis, with ultimate completion targeted for July 27, 2017.</p>
- <p>The National Cancer Institute awarded a purchase order to GenScript USA Inc. for $6,126.56 on July 28, 2017, for sequencing services. Work is performed in Piscataway, New Jersey. The order is firm fixed price with an ultimate completion date of September 30, 2017.</p>
- <p>The National Cancer Institute awarded a purchase order to Genscript USA Inc. for $11,578.26 on June 11, 2019, covering custom gene synthesis, custom peptide synthesis, direct cloning, plasmid preparation, and crude peptide library services. No set-aside was used. Work is performed in Piscataway, New Jersey. The order was firm fixed price with an ultimate completion date of July 11, 2019.</p>
- <p>The National Cancer Institute awarded a purchase order to Genscript USA Inc. for $11,484.18 on August 12, 2019, for sequencing services. Work is performed in Piscataway, New Jersey. The order carries a firm fixed price and is scheduled for completion by September 11, 2019.</p>
- <p>The National Cancer Institute awarded a purchase order to Genscript USA Inc. for $3,633.62 on August 22, 2017. The order is for peptide services and carries no set-aside designation. Work is performed in Piscataway, New Jersey. The purchase order is firm fixed price and concludes September 30, 2017.</p>
- <p>The National Cancer Institute awarded a purchase order to Genscript USA Inc. valued at $8,786.64 on August 15, 2017, for peptide services. Work is performed in Piscataway, New Jersey. The order is firm fixed price with an ultimate completion date of September 30, 2017. No set-aside category was applied.</p>
- <p>The National Cancer Institute awarded a purchase order to Genscript USA Inc. for peptide services on August 17, 2017, with a ceiling value of $8,353.96 and an ultimate completion date of September 30, 2017. Work is performed in Piscataway, New Jersey. The order is a firm fixed price purchase order with no set-aside.</p>
- <p>The National Cancer Institute awarded a purchase order to Genscript USA Inc. valued at $3,964.20 on September 5, 2017, for peptide services. Work is performed in Piscataway, New Jersey. The order carries a firm fixed price structure and ultimate completion date of October 5, 2017.</p>
- <p>The National Cancer Institute awarded a purchase order to Genscript USA Inc. for peptide services valued at $7,701.00 on July 11, 2017. Place of performance is Piscataway, New Jersey. The order is firm fixed price with an ultimate completion date of August 9, 2017.</p>
- <p>The National Cancer Institute awarded a purchase order to Genscript USA Inc. for $3,567.96 on August 11, 2017, for peptide services. Work is performed at the awardee's facility in Piscataway, New Jersey. The order is firm fixed price and carries a completion date of September 30, 2017.</p>